NICM
DGX icon

Neo Ivy Capital Management’s Quest Diagnostics DGX Stock Holding History

Neo Ivy Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5K Buy
+191
New +$37.5K 0.01% 314
2025
Q3 		– Sell
-4,910
Closed -$882K – 418
2025
Q2 		$882K Buy
+4,910
New +$853K 0.28% 130
2025
Q1 		– Sell
-24,681
Closed -$3.72M – 320
2024
Q4 		$3.72M Buy
+24,681
New +$3.84M 0.75% 32
2023
Q4 		– Sell
-5,404
Closed -$659K – 334
2023
Q3 		$659K Buy
+5,404
New +$720K 0.29% 112
2022
Q4 		– Sell
-20
Closed -$2K – 388
2022
Q3 		$2K Buy
+20
New +$2.63K 0.01% 358
2022
Q2 		– Sell
-462
Closed -$64K – 454
2022
Q1 		$64K Buy
462
+303
+191% +$42.2K 0.06% 353
2021
Q4 		$28K Sell
159
-1,037
-87% -$158K 0.04% 339
2021
Q3 		$136K Buy
+1,196
New +$175K 0.16% 201
2021
Q2 		– Sell
-44
Closed -$6K – 487
2021
Q1 		$6K Sell
44
-4,871
-99% -$600K 0.01% 431
2020
Q4 		$586K Buy
4,915
+4,713
+2,333% +$575K 0.65% 38
2020
Q3 		$23K Sell
202
-994
-83% -$117K 0.02% 406
2020
Q2 		$136K Sell
1,196
-753
-39% -$79.9K 0.16% 201
2020
Q1 		$157K Buy
+1,949
New +$202K 0.26% 157
2019
Q3 		– Sell
-1,855
Closed -$189K – 310
2019
Q2 		$189K Buy
+1,855
New +$178K 0.11% 209

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Neo Ivy Capital Management's DGX Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 191 shares worth $40.5K. The stake represents 0.01% of the portfolio and ranks #314 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in DGX as recently as Q2 2025.

Neo Ivy Capital Management first reported a position in DGX in Q2 2019 and has held it in 14 quarters since. The position peaked at $3.72M in Q4 2024. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Neo Ivy Capital Management held 191 shares of Quest Diagnostics worth $40.5K as of Q2 2026.
  • Quest Diagnostics was a new Neo Ivy Capital Management position in Q2 2026.
  • Quest Diagnostics made up 0.01% of Neo Ivy Capital Management's portfolio in Q2 2026, its #314 holding.
  • Neo Ivy Capital Management first reported a position in Quest Diagnostics in Q2 2019 and has held it in 14 quarters since.
  • Neo Ivy Capital Management's Quest Diagnostics position peaked at $3.72M in Q4 2024.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.